Skip to content

Funding Opportunities, December 6

Limited Submission Opportunities

Click here to sign up for the Limited Submissions mailing list to receive funding opportunity announcements.

Contact Hannah Schmidt (hschmidt@utk.edu) if you have any questions.

NIH Opportunities

Join the UT NIH Research Community by contacting Jennifer Webster (jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlinesfor Investigator-Initiated Research Projects
  • NIH Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21 Clinical Trial Optional) (PAR-18-242)
  • NIH Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)(PAR-18-189)
  • NIH Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)(PAR-18-190)
  • NIH Pathway to Independence Award (Parent K99/R00 – Clinical Trial Required)(PA-18-397)
  • NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed)(PA-18-398)
  • NIH Research on Autism Spectrum (R03-Clinical Trial Optional)(PA-18-399)
  • NIH Research on Autism Spectrum (R21- Clinical Trial Optional)(PA-18-400)
  • NIH Research on Autism Spectrum (R01- Clinical Trial Optional)(PA-18-401)
  • NIH Surgical Disparities Research (R01 Clinical Trial Optional) (PAR-18-288)
  • NCATS Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trials Not Allowed)(PAR-18-462)
  • NCATS / NIBIB NIH-CASIS Coordinated Microphysiological Systems Program for Translational Research in Space (UG3/UH3) (Clinical Trials Not Allowed)(RFA-TR-18-001)

  • NCCIH Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44 Clinical Trial Optional) (PAS-18-120)
  • NCCIH Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42 Clinical Trial Optional)(PAS-18-121)
  • NCCIH Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 – Clinical Trials Required)(PAR-18-417)
  • NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)(PAR-18-125)
  • NCI Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional)(PAR-18-250)
  • NCI Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional)(PAR-18-251)
  • NCI Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)(PAR-18-246)
  • NCI Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)(PAR-18-247)
  • NCI Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) (PAR-18-292)
  • NCI Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional)(PAR-18-024)
  • NCI Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)(PAR-18-248)
  • NCI Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)(PAR-18-249)
  • NCI / NIBIB Image-guided Drug Delivery (R01 Clinical Trial Optional)(PAR-18-252)
  • NCI / NIDA Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)(PAR-18-022)
  • NCI / NIDA Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional)(PAR-18-023)
  • NHLBI Career Transition Award for Intramural Fellows (K22) (No Independent Clinical Trials)(PAR-18-416)
  • NHLBI Career Transition Award for Intramural Fellows (K22) (Clinical Trials Required)(PAR-18-424)
  • NHLBI Clinical Trial Pilot Studies (R34 – Clinical Trial Optional)(PAR-18-463)
  • NHLBI Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01 Clinical Trial Optional)(PAR-18-133)
  • NIA Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)(PAS-18-187)
  • NIA Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)(PAS-18-188)
  • NIA Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer’s Disease (R24 – Clinical Trial Not Allowed)(RFA-AG-18-024)
  • NIA Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)(PAR-18-185)
  • NIA Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional)(PAR-18-186)
  • NIA T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)(PAR-18-183)
  • NIA T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional) (PAR-18-184)
  • NIAAA Epidemiology and Prevention in Alcohol Research (R01 – Clinical Trial Optional)(PA-18-390)
  • NIAAA Epidemiology and Prevention in Alcohol Research (R21 – Clinical Trial Optional)(PA-18-391)
  • NIAAA Epidemiology and Prevention in Alcohol Research (R03 – Clinical Trial – Optional)(PA-18-413)
  • NIAAA Wearable Alcohol Biosensors (R43/R44 Clinical Trial Optional) (PAR-18-204)
  • NIAID Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)(RFA-AI-17-042)
  • NIAID / NIDA / NIMH Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01 Clinical Trial Optional)(PAR-18-254)
  • NIBIB Research Project Grant (R01 Clinical Trial Required)(PA-18-418)
  • NICHD Research Education Programs (R25 Clinical Trial Optional)(PAR-18-217)
  • NICHD / NIDCD Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)(PAR-18-214)
  • NICHD / NIDCD Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)(PAR-18-215)
  • NIDA Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)(PAR-18-226)
  • NIDA Core “Center of Excellence” Grant Program (P30 Clinical Trial Optional)(PAR-18-225)
  • NIDA Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01 Clinical Trial Optional)(PAR-18-220)
  • NIDA Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3 Clinical Trial Optional)(PAR-18-221)
  • NIDA Program Project Grant Applications (P01, Clinical Trial Optional)(PAR-18-425)
  • NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)(PAR-18-224)
  • NIDA / NCI / NIAAA Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)(PAR-18-222)
  • NIDA / NIAAA Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) (PAR-18-223)
  • NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) (PAR-18-108)
  • NIDDK High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)(PAR-18-111)
  • NIDDK Innovative Research in HIV in Kidney, Urology, and Hematology (R01 Clinical Trial Optional)(RFA-DK-17-037)
  • NIDDK Mentored Research Scientist Development Award (K01-Clinical Trial Required)(PAR-18-418)
  • NIDDK Mentored Research Scientist Development Award (K01-No Independent Clinical Trials)(PAR-18-419)
  • NIDDK Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)(PAR-18-414)
  • NIDDK Multi-Center Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)(PAR-18-415)
  • NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)(PAR-18-423)
  • NIGMS Centers of Biomedical Research Excellence (COBRE) (P20 Clinical Trial Optional (PAR-18-266)
  • NIGMS Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 Clinical Trial Optional)(PAR-18-265)
  • NIGMS Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III – Transitional Centers (P30 Clinical Trial Optional)(PAR-18-263)
  • NIGMS Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20 Clinical Trial Optional)(PAR-18-264)
  • NIMH Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) (PA-18-276)
  • NIMH Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional)(PA-18-274)
  • NIMH Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional)(PAR-18-269)
  • NIMH Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01 Clinical Trial Optional) (PA-18-281)
  • NIMH Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional)(PA-18-271)
  • NIMH Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21 Clinical Trial Optional)(PA-18-272)
  • NIMH Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01 Clinical Trial Optional) (PA-18-273)
  • NIMH / NIDA Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R21 Clinical Trial Optional)(PA-18-275)
  • NIMH / NINR Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21 Clinical Trial Optional)(PA-18-277)
  • NIMH / NINR Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01 Clinical Trial Optional)(PA-18-278)
  • NIMH / NINR Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01 Clinical Trial Optional) (PA-18-279)
  • NIMH / NINR Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21 Clinical Trial Optional) (PA-18-280)
  • NIMHD Research on Pre-Exposure Prophylaxis (PrEP) to Prevent HIV in Health Disparity Populations (R01-Clinical Trial Not Allowed)(RFA-MD-18-003)
  • NIMHD Youth Violence Prevention Interventions that Incorporate Racism/Discrimination Prevention (R01-Clinical Trial Required) (RFA-MD-18-005)
  • NIMHD / NCI / NIAMS Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional)(PAR-18-289)
  • NIMHD / NIAAA / NIDA Health Services Research on Minority Health and Health Disparities (R01 Clinical Trial Optional)(PAR-18-286)
  • NIMHD / NIAAA / NIDA Health Services Research on Minority Health and Health Disparities (R21 Clinical Trial Optional)(PAR-18-287)
  • NINDS Efficacy Clinical Trials (U01) – Clinical Trial Required(PAR-18-422)
  • NINDS Exploratory Clinical Trials (U01 – Clinical Trials Required)(PAR-18-420)
  • NINDS Program Project Grant (P01) – Clinical Trial Optional(PAR-18-421)
  • NINR Building Evidence: Effective Palliative/End of Life Care Interventions (R01 Clinical Trial Optional)(PAR-18-173)

NSF Opportunities

Please contact Sharon Pound (spound@utk.edu) regarding your interest in NSF opportunities.

  • Resource Implementations for Data Intensive Research in the Social, Behavioral and Economic Sciences (RIDIR) NSF 18-517
  • National Robotics Initiative 2.0: Ubiquitous Collaborative Robots (NRI-2.0) NSF 18-518
  • Smart and Connected Communities (S&CC) NSF 18-520
  • NSF/CASIS Collaboration on Fluid Dynamics and Particulate and Multiphase Processes Research on the International Space Station to Benefit Life on Earth NSF 18-521

The flagship campus of the University of Tennessee System and partner in the Tennessee Transfer Pathway.

Report an accessibility barrier